A First Nations leader says opening the market on generic OxyContin is another blow to remote communities dealing with an epidemic of drug abuse.
The federal government announced Monday that it will not delay or intervene in the approval of generic manufacturing of the drug. Nishnawbe Aski Nation deputy grand chief Alvin Fiddler said he’s disappointed with the decision.
“With OxyContin clones on the market, it just means more drug flow to the north. NAN is disappointed with Federal Minister Aglukkaq’s refusal to intervene in the approval of generic versions of the drug,” Fiddler stated in a media release.
“While we appreciate the Minister’s distinction between science and politics, NAN First Nations are experiencing extreme levels of addiction and require extreme solutions.”
